Saffron Dosage for Mild-to-Moderate Depression
For an adult with mild-to-moderate depression not taking prescription antidepressants, use 28-30 mg of standardized saffron stigma extract daily for at least 8-12 weeks.
Recommended Dosing Protocol
The evidence consistently supports 30 mg per day as the standard therapeutic dose, though recent high-quality trials demonstrate efficacy at slightly lower doses:
- Standard dose: 30 mg/day of standardized saffron stigma extract, typically divided into two 15 mg doses 1, 2, 3, 4
- Alternative validated dose: 28 mg/day (single daily dose) has shown significant efficacy in recent trials 1
- Minimum effective dose: 15 mg/day demonstrated benefit in subclinical depression 5
Treatment Duration
- Initial trial period: 8-12 weeks to assess response 1, 2
- Clinically meaningful improvements typically emerge by 4 weeks (Day 28), with continued benefit through 8 weeks 5
- Some older trials used 6-week protocols with success 4
Key Clinical Considerations
Product Standardization Matters
The extract must be standardized from saffron stigmas (not petals, which have different constituent profiles). Look for products standardized to specific bioactive compounds (crocin, safranal) 2. Validated commercial extracts include Affron® (used at 28 mg) 1 and UO SAF 02 (used at 15 mg) 5.
Expected Outcomes
In the largest trial to date (n=202), 72.3% of participants achieved clinically significant improvement (≥7-point reduction on depression scales) with 28 mg saffron versus 54.3% with placebo 1. The effect size is moderate (Cohen's d = 0.39-0.44) 1.
Safety Profile
Saffron demonstrates excellent tolerability with no serious adverse events reported across trials 5, 1, 3. This represents a significant advantage over conventional antidepressants, which show higher rates of adverse events and treatment discontinuation 6.
Common Pitfalls to Avoid
Don't use petal extracts: Clinical evidence specifically supports stigma extracts; petal preparations have distinct chemistry and unclear efficacy 2
Don't expect immediate results: Allow the full 8-12 week trial before concluding treatment failure, though some benefit may appear by week 4
Verify product quality: Use standardized extracts with documented constituent levels rather than culinary saffron or unstandardized supplements
Monitor for large placebo response: Recent trials show substantial placebo effects (54% response rate), so clinical judgment remains essential 1
Positioning in Treatment Algorithm
Current evidence positions saffron as a third-line complementary option for mild depressive episodes and potential adjunct in moderate depression 2. Given the comparable efficacy to SSRIs in head-to-head trials (though underpowered) and superior tolerability profile, saffron represents a reasonable first-line option for patients preferring non-pharmaceutical approaches or those with contraindications to conventional antidepressants 2.
The 2023 American College of Physicians guideline found that nonpharmacologic treatments generally achieve similar efficacy to second-generation antidepressants for moderate-to-severe depression, with lower adverse event rates 6, supporting the use of evidence-based botanical interventions like saffron in appropriate clinical contexts.